MUFT, MUFT, MUFT! 2:1, 3:1, and 1:1 Bonus Shares: From April 15–19, three multibagger penny stocks will become ex-bonus

Do you recall the well-known scene in Jab We Met when Geet exclaims, “MUFT, MUFT, MUFT”? Investors in three penny stocks—Integrated Industries, Naapbooks, and Shukra Pharmaceuticals—will experience just that. The week of April 15–19, when trading takes place, will be quite active for penny stocks that are going ex-bonus. Bonus shares with the greatest ratio will be 3:1, followed by 2:1 and 1:1. With returns ranging from 270% to 1,055% from their 52-week lows, these penny stocks are multibaggers.

Bonus shares are corporate initiatives implemented by publicly traded firms. Companies that use this policy only award bonus shares to current shareholders. Investors are not required to pay any money for these shares in this case. To put it simply, extra shares are completely free! Interestingly, the face value of bonus shares doesn’t change.

The following information relates to these three penny stocks, including the record date, ex-bonus date, and bonus shares:

1. Integrated Industries Bonus Issue: Tuesday, April 16, 2024, has been set as the record date by the packaged food firm Integrated Industries to determine which shareholders are eligible for Bonus shares to be issued. The corporation will award shareholders listed on the record date with one bonus share for each existing equity share.

Integrated Industries Limited (ITL), which was incorporated in 1995, is now involved in the production of bakery goods, processed foods, and both organic and inorganic food products.

Following April 12 trading hours, the share price of Integrated Industries on the BSE was Rs 628 each, down 1.88%, with a market capitalization of Rs 601.56 crore. The stock is up 40% on the BSE year to date, despite the most recent decline. The integrated share is up a massive 1,053.14% from its 52-week low of Rs 54.46 a share, but it is still a few rupees short of its 52-week high of Rs 677 apiece.

2. Naapbooks Bonus Issue: On Saturday, April 6, 2024, the company’s extraordinary general meeting approved the issuance of 2 (two) new equity shares of Rs. 10/- (Rupees Ten) each for every 1 (one) existing equity share of Rs. 10/- (Rupees Ten) each. Naapbooks, a computer and software consulting firm, set Friday, April 19, 2024, as the Record Date to determine the eligibility of shareholders entitled to the issuance of Bonus Equity Shares.

The bonus issue ratio is thus 2:1. With a market valuation of Rs 80.49 crore, Naapbook shares froze on April 12 at its 5% upper circuit, or Rs 267.70 a share. The stock has risen 176% on the BSE YTD so far. Naapbooks is now trading higher by 277.04% from its 52-week low of Rs 71 each, and it is also close to its 52-week high of Rs 272 apiece.

Naapbooks is a highly advanced FinTech business with seven years of extensive expertise in the IT sector.

3. Shukra Pharmaceuticals: As the bonus issue record date draws closer, this penny stock is just one more to test upper circuit boundaries. The closing price of Shukra’s shares was Rs 326 per share, up 2% from its April 12 peak. The market capitalization of the business was Rs 356.87 crore. YTD, the BSE stock has had a 169% rise.

Additionally, this company is selling at a 497.07% premium over its 52-week low of Rs 54.60 per share, and it is close to its 52-week high of Rs 388 per share.

The pharmaceutical business has set Saturday, April 20, 2024, as the record date in order to determine whether stockholders are eligible to receive Bonus Shares. After being allocated, the Bonus Shares will rank equally with the existing equity shares and have the same rights. They will also be eligible to fully participate in any dividend and other corporate action that is proposed and announced after the new equity shares are awarded.

The corporation has declared a 3:1 bonus share ratio. This indicates that for every one (0ne) fully paid-up equity share of Rs. 10/- [Rupees Ten only] owned by the company’s members as of the Record Date, it would issue three [Three] fully paid-up bonus equity shares.

Shukra is dedicated to providing top-notch service in both domestic and international markets. Shukra Pharmaceuticals is a well-known public limited company with production sites across the world.

Benefits of Bonus Shares: According to BSE FAQs, bonus shares enhance equity share liquidity on stock exchanges by increasing the number of outstanding equity shares. Bonus issues also decrease listed businesses’ excess and free reserves while creating implicit value per equity share.